From: Stock Gumshoe<travis@stockgumshoe.com>
Subject: Stock Gumshoe Daily Update
Preheader: Who resembles a pre-IPO Facebook?
Reply: travis@stockgumshoe.com
You're receiving this email newsletter because you
or someone using newsletter@newslettercollector.com signed up for the Stock Gumshoe Daily Update  
Please unsubscribe if you don't want Stock Gumshoe emails. 
 
If this message is not clearly formatted in your email, click here for the web version

DAILY UPDATE
January 4, 2018
Dear Valued Reader,

Sorry for the double mailing this evening, we sent out the newsletter with the wrong link below... it has been fixed now.  Thanks for your patience!

Happy New Year!  We start out our year of teaser solutions by checking out a pitch from the Motley Fool... we're told that "Renowned investor Tom Gardner has identified a stock he thinks resembles Facebook in its early days."   So what is it?  Just click below to...

Miss anything in the holiday hullabaloo?  The most-discussed teaser solution as we closed out last year was Louis Navellier's "Cryptocurrency Master Key" pitch... he teased "a unique way to unlock as much as $43,098 (possibly more) beginning Thursday, February 22nd from the booming crypto-markets…" This apparently lets you make money from bitcoin, ethereum, or whatever other alt-currency catches the public's fancy next.  So what is this "Master Key?"  Is it real? Our story is here.

We also solved a couple Motley Fool teaser pitches this week... first was one for a "Rare Recent IPO Buy Alert" that Tom Gardner was excited about, and you can see our solution to that one here.

And the other was a solution to Motley Fool's "What Every Apple Investor Needs to Know" spiel -- so what are they hinting at in their ads for a David Gardner pick for Rule Breakers?   Apparently "one small American company holds the key patents" for the next wave of iPhone mania, we're teased... and the answer?  Just a click away for you, dear reader.

We also got a new piece from Doc Gumshoe this week, with a good overview of the FDA review process and patents that might help folks who are thinking about investing in the pharma sector... his piece is called The Regulatory Maze: What It Means For Our Health

And we had several new pieces for the Irregulars, our most favoritest readers and the folks who keep Stock Gumshoe going... you can see links to those pieces, including some updates from Dr. KSS and a new buy in my Real Money Portfolio, in the Irregulars Corner below.


Disclaimer: Nothing in this email or in the linked articles should be considered to be individual investment advice -- we can't tell you what you should do with your money, we can just share our opinions and perspective. Our authors try to use reliable information sources but also make mistakes of both fact and judgement on occasion, so all assertions should be checked and confirmed. You should speak with your financial advisor and understand everything fully before committing money to any investment.

Most issues of this email newsletter include advertising, and it should not be assumed that the presence of an advertisement means that the product or service advertised is endorsed by Stock Gumshoe or the author. For full disclaimers, disclosure information, and privacy policies please see the prominent links at the bottom of each page at StockGumshoe.com.

If you wish to unsubscribe to these mailings, there are links at both the bottom and top of this email that you can use to do so permanently and safely, we have no wish to email people who don't want to receive these messages. Please note that unsubscribing using the link below applies only to receiving emails, if you are a member of the Stock Gumshoe Irregulars that membership will not automatically change or be canceled. Please contact us if you need to change a paid membership.
Unsubscribe
Stock Gumshoe, 351 Pleasant St., Suite B #205, Northampton, MA 01060